Blood: Exogenous antigens successfully significantly enhance immune depletion of HIV CAR T cell amplification
-
Last Update: 2020-07-16
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
!---- CAR T cells targeting CD19 plus hematologic malignancies, springing up, quickly becoming a promising new treatment, on the contrary, the results of several CAR T-cell studies of infectious diseases such as HIV-1 are less convincingthese challenges may be due to the lower level of antigens in patients with ART inhibition compared to patients with hematologic malignanciesIn this study, Rust et altested ART-suppressed HIV-1 infection strategies in their sophisticated non-human primate models to overcome these limitations and challengesresearchers first optimized the production of CAR T cells to maintain a subset of central memory, consistent with current clinical patternsRust and other assumptions, under ART inhibition conditions, additional exogenous antigens may be required to help CAR-T cell amplification and maintenance, Rust and others studied four art-suppressed rhesus monkeys infected with the simian/human immunodeficiency virus (SHIV) and injected them with viral-specific CD4CAR T cells, and then supplemented with additional infusion cell-related HIV-1 shells (Env)Env promotes significant and unprecedented amplification of virus-specific CAR-T cells in the body, followed by the discontinuation of ART therapy, which significantly delayed the virus rebound in the Env treatment group compared to the control group (p-0.014)anti-PD-1 antibodies that were resuscitated by rhesus monkeys in two animals where CAR-T cells declined to reverse PD-1-dependent immune depletionimmune checkpoint block triggers depleted CAR T cell amplification, which then reduces the viral load to undetectable levelsin summary, the above results show that additional cell-related antigens can enable CAR T cells to grow robustly in environments where antigens are scarceknow that this study is the first to reveal that virus-specific CAR T cells can amplification in infected, inhibited host bodies and delay/control virus recurrence
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.